drugset / Trial / NCT00313547

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

NCT00313547 ↗

Phase 4 Terminated 40 enrolled Montreal Heart Institute Pfizer · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the impact of two blood pressure lowering treatments (high dose quinapril versus low dose quinapril plus amlodipine) on variations in heart rate over 24 hours.

Timeline

Start
2006-04
Primary completion
2007-04
Completion
2008-03

Outcome

Outcome not reported

Stopped (Enrollment): “Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —
Subject Quinapril Small molecule 10 mg —
Subject Quinapril Small molecule 40 mg —

Indications